Results 191 to 200 of about 407,623 (356)

Smaller hamstrings autograft size after primary ACL reconstruction is associated with higher odds for graft failure: A meta‐analysis on autografts sizes covering 46,268 patients

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose To investigate the association between autograft size and graft failure for hamstrings tendon (HT), patellar tendon (PT) and quadriceps tendon (QT) autografts. Methods Medline, PubMed, Cochrane Library, Embase, Amed and Web of Science were searched at four separate time points, with the most recent search in February 2025.
Rebecca Hamrin Senorski   +8 more
wiley   +1 more source

Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1. [PDF]

open access: yesESMO Open
Vaklavas C   +17 more
europepmc   +1 more source

Tips and Tricks for Organizing a Summer School—A Case Study Based on the “Nexus of Organic Matter Analytical Developments” School

open access: yesLimnology and Oceanography Bulletin, EarlyView.
Abstract In June 2025 we organized and ran the first “Nexus of Organic Matter Analytical Developments” (NOMAD) Summer School at the Tjärnö Marine Laboratory in Sweden. In this article, we describe its development and implementation, with the aim of offering practical insights into the planning process, a generalizable framework for future summer ...
Alexander J. Craig   +14 more
wiley   +1 more source

Are open-access fees undermining science as a public good? [PDF]

open access: yesEXCLI J
Quintans-Júnior L   +2 more
europepmc   +1 more source

DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA for injection (DAXI), a novel botulinum toxin (BoNT) formulated with a custom‐engineered peptide, was recently approved for treating cervical dystonia (CD). DAXI demonstrated a long duration of symptom relief in Phase 3 trials. Objective To report findings from PrevU, an early experience, real‐world observational
Laxman Bahroo   +10 more
wiley   +1 more source

Publish or Perish: The Cost of Publication in Orthopaedic Journals. [PDF]

open access: yesJ Am Acad Orthop Surg Glob Res Rev
Lutnick E   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy